Extrahepatic Anomalies in Infants With Biliary Atresia: Results of a Large Prospective North American Multicenter Study
The etiology of biliary atresia (BA) is unknown. Given that patterns of anomalies might provide etiopathogenetic clues, we used data from the North American Childhood Liver Disease Research and Education Network to analyze patterns of anomalies in infants with BA. In all, 289 infants who were enroll...
Saved in:
Published in | Hepatology (Baltimore, Md.) Vol. 58; no. 5; pp. 1724 - 1731 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Wolters Kluwer Health, Inc
01.11.2013
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The etiology of biliary atresia (BA) is unknown. Given that patterns of anomalies might provide etiopathogenetic clues, we used data from the North American Childhood Liver Disease Research and Education Network to analyze patterns of anomalies in infants with BA. In all, 289 infants who were enrolled in the prospective database prior to surgery at any of 15 participating centers were evaluated. Group 1 was nonsyndromic, isolated BA (without major malformations) (n = 242, 84%), Group 2 was BA and at least one malformation considered major as defined by the National Birth Defects Prevention Study but without laterality defects (n = 17, 6%). Group 3 was syndromic, with laterality defects (n = 30, 10%). In the population as a whole, anomalies (either major or minor) were most prevalent in the cardiovascular (16%) and gastrointestinal (14%) systems. Group 3 patients accounted for the majority of subjects with cardiac, gastrointestinal, and splenic anomalies. Group 2 subjects also frequently displayed cardiovascular (71%) and gastrointestinal (24%) anomalies; interestingly, this group had genitourinary anomalies more frequently (47%) compared to Group 3 subjects (10%). Conclusion: This study identified a group of BA (Group 2) that differed from the classical syndromic and nonsyndromic groups and that was defined by multiple malformations without laterality defects. Careful phenotyping of the patterns of anomalies may be critical to the interpretation of both genetic and environmental risk factors associated with BA, allowing new insight into pathogenesis and/or outcome. (Hepatology 2013;58:1724–1731) |
---|---|
AbstractList | The etiology of biliary atresia (BA) is unknown. Given that patterns of anomalies might provide etiopathogenetic clues, we used data from the North American Childhood Liver Disease Research and Education Network to analyze patterns of anomalies in infants with BA. In all, 289 infants who were enrolled in the prospective database prior to surgery at any of 15 participating centers were evaluated. Group 1 was nonsyndromic, isolated BA (without major malformations) (n = 242, 84%), Group 2 was BA and at least one malformation considered major as defined by the National Birth Defects Prevention Study but without laterality defects (n = 17, 6%). Group 3 was syndromic, with laterality defects (n = 30, 10%). In the population as a whole, anomalies (either major or minor) were most prevalent in the cardiovascular (16%) and gastrointestinal (14%) systems. Group 3 patients accounted for the majority of subjects with cardiac, gastrointestinal, and splenic anomalies. Group 2 subjects also frequently displayed cardiovascular (71%) and gastrointestinal (24%) anomalies; interestingly, this group had genitourinary anomalies more frequently (47%) compared to Group 3 subjects (10%).UNLABELLEDThe etiology of biliary atresia (BA) is unknown. Given that patterns of anomalies might provide etiopathogenetic clues, we used data from the North American Childhood Liver Disease Research and Education Network to analyze patterns of anomalies in infants with BA. In all, 289 infants who were enrolled in the prospective database prior to surgery at any of 15 participating centers were evaluated. Group 1 was nonsyndromic, isolated BA (without major malformations) (n = 242, 84%), Group 2 was BA and at least one malformation considered major as defined by the National Birth Defects Prevention Study but without laterality defects (n = 17, 6%). Group 3 was syndromic, with laterality defects (n = 30, 10%). In the population as a whole, anomalies (either major or minor) were most prevalent in the cardiovascular (16%) and gastrointestinal (14%) systems. Group 3 patients accounted for the majority of subjects with cardiac, gastrointestinal, and splenic anomalies. Group 2 subjects also frequently displayed cardiovascular (71%) and gastrointestinal (24%) anomalies; interestingly, this group had genitourinary anomalies more frequently (47%) compared to Group 3 subjects (10%).This study identified a group of BA (Group 2) that differed from the classical syndromic and nonsyndromic groups and that was defined by multiple malformations without laterality defects. Careful phenotyping of the patterns of anomalies may be critical to the interpretation of both genetic and environmental risk factors associated with BA, allowing new insight into pathogenesis and/or outcome.CONCLUSIONThis study identified a group of BA (Group 2) that differed from the classical syndromic and nonsyndromic groups and that was defined by multiple malformations without laterality defects. Careful phenotyping of the patterns of anomalies may be critical to the interpretation of both genetic and environmental risk factors associated with BA, allowing new insight into pathogenesis and/or outcome. The etiology of biliary atresia (BA) is unknown. Given that patterns of anomalies might provide etiopathogenetic clues, we used data from the North American Childhood Liver Disease Research and Education Network to analyze patterns of anomalies in infants with BA. In all, 289 infants who were enrolled in the prospective database prior to surgery at any of 15 participating centers were evaluated. Group 1 was nonsyndromic, isolated BA (without major malformations) (n = 242, 84%), Group 2 was BA and at least one malformation considered major as defined by the National Birth Defects Prevention Study but without laterality defects (n = 17, 6%). Group 3 was syndromic, with laterality defects (n = 30, 10%). In the population as a whole, anomalies (either major or minor) were most prevalent in the cardiovascular (16%) and gastrointestinal (14%) systems. Group 3 patients accounted for the majority of subjects with cardiac, gastrointestinal, and splenic anomalies. Group 2 subjects also frequently displayed cardiovascular (71%) and gastrointestinal (24%) anomalies; interestingly, this group had genitourinary anomalies more frequently (47%) compared to Group 3 subjects (10%). Conclusion: This study identified a group of BA (Group 2) that differed from the classical syndromic and nonsyndromic groups and that was defined by multiple malformations without laterality defects. Careful phenotyping of the patterns of anomalies may be critical to the interpretation of both genetic and environmental risk factors associated with BA, allowing new insight into pathogenesis and/or outcome. (Hepatology 2013;58:1724-1731) [PUBLICATION ABSTRACT] The etiology of biliary atresia (BA) is unknown. Given that patterns of anomalies might provide etiopathogenetic clues, we used data from the North American Childhood Liver Disease Research and Education Network to analyze patterns of anomalies in infants with BA. In all, 289 infants who were enrolled in the prospective database prior to surgery at any of 15 participating centers were evaluated. Group 1 was nonsyndromic, isolated BA (without major malformations) (n = 242, 84%), Group 2 was BA and at least one malformation considered major as defined by the National Birth Defects Prevention Study but without laterality defects (n = 17, 6%). Group 3 was syndromic, with laterality defects (n = 30, 10%). In the population as a whole, anomalies (either major or minor) were most prevalent in the cardiovascular (16%) and gastrointestinal (14%) systems. Group 3 patients accounted for the majority of subjects with cardiac, gastrointestinal, and splenic anomalies. Group 2 subjects also frequently displayed cardiovascular (71%) and gastrointestinal (24%) anomalies; interestingly, this group had genitourinary anomalies more frequently (47%) compared to Group 3 subjects (10%). This study identified a group of BA (Group 2) that differed from the classical syndromic and nonsyndromic groups and that was defined by multiple malformations without laterality defects. Careful phenotyping of the patterns of anomalies may be critical to the interpretation of both genetic and environmental risk factors associated with BA, allowing new insight into pathogenesis and/or outcome. The etiology of biliary atresia (BA) is unknown. Given that patterns of anomalies might provide etiopathogenetic clues, we used data from the North American Childhood Liver Disease Research and Education Network to analyze patterns of anomalies in infants with BA. In all, 289 infants who were enrolled in the prospective database prior to surgery at any of 15 participating centers were evaluated. Group 1 was nonsyndromic, isolated BA (without major malformations) (n = 242, 84%), Group 2 was BA and at least one malformation considered major as defined by the National Birth Defects Prevention Study but without laterality defects (n = 17, 6%). Group 3 was syndromic, with laterality defects (n = 30, 10%). In the population as a whole, anomalies (either major or minor) were most prevalent in the cardiovascular (16%) and gastrointestinal (14%) systems. Group 3 patients accounted for the majority of subjects with cardiac, gastrointestinal, and splenic anomalies. Group 2 subjects also frequently displayed cardiovascular (71%) and gastrointestinal (24%) anomalies; interestingly, this group had genitourinary anomalies more frequently (47%) compared to Group 3 subjects (10%). Conclusion: This study identified a group of BA (Group 2) that differed from the classical syndromic and nonsyndromic groups and that was defined by multiple malformations without laterality defects. Careful phenotyping of the patterns of anomalies may be critical to the interpretation of both genetic and environmental risk factors associated with BA, allowing new insight into pathogenesis and/or outcome. (Hepatology 2013;58:1724–1731) |
Author | Ng, Vicky L. Whitington, Peter F. Schwarz, Kathleen B. Karpen, Saul J. Moore, Jeffrey Magee, John C. Haber, Barbara H. Murray, Karen F. Wang, Kasper S. Shneider, Benjamin L. Molleston, Jean P. Turmelle, Yumirle P. Bezerra, Jorge A. Mack, Cara L. Romero, René Bove, Kevin Kerkar, Nanda Sokol, Ronald J. Rosenthal, Philip |
Author_xml | – sequence: 1 givenname: Kathleen B. surname: Schwarz fullname: Schwarz, Kathleen B. organization: Johns Hopkins Medical Institutions – sequence: 2 givenname: Barbara H. surname: Haber fullname: Haber, Barbara H. organization: Children's Hospital of Philadelphia – sequence: 3 givenname: Philip surname: Rosenthal fullname: Rosenthal, Philip organization: UCSF School of Medicine – sequence: 4 givenname: Cara L. surname: Mack fullname: Mack, Cara L. organization: University of Colorado School of Medicine – sequence: 5 givenname: Jeffrey surname: Moore fullname: Moore, Jeffrey organization: University of Michigan School of Public Health – sequence: 6 givenname: Kevin surname: Bove fullname: Bove, Kevin organization: Cincinnati Children's Hospital Medical Center – sequence: 7 givenname: Jorge A. surname: Bezerra fullname: Bezerra, Jorge A. organization: Cincinnati Children's Hospital Medical Center – sequence: 8 givenname: Saul J. surname: Karpen fullname: Karpen, Saul J. organization: Texas Children's Hospital – sequence: 9 givenname: Nanda surname: Kerkar fullname: Kerkar, Nanda organization: Mount Sinai School of Medicine – sequence: 10 givenname: Benjamin L. surname: Shneider fullname: Shneider, Benjamin L. organization: Children's Hospital Pittsburgh of UPMC – sequence: 11 givenname: Yumirle P. surname: Turmelle fullname: Turmelle, Yumirle P. organization: Washington University – sequence: 12 givenname: Peter F. surname: Whitington fullname: Whitington, Peter F. organization: Children's Memorial Hospital – sequence: 13 givenname: Jean P. surname: Molleston fullname: Molleston, Jean P. organization: Indiana University – sequence: 14 givenname: Karen F. surname: Murray fullname: Murray, Karen F. organization: Seattle Children's and University of Washington – sequence: 15 givenname: Vicky L. surname: Ng fullname: Ng, Vicky L. organization: University of Toronto – sequence: 16 givenname: René surname: Romero fullname: Romero, René organization: Emory University – sequence: 17 givenname: Kasper S. surname: Wang fullname: Wang, Kasper S. organization: Keck School of Medicine University of Southern California – sequence: 18 givenname: Ronald J. surname: Sokol fullname: Sokol, Ronald J. organization: University of Colorado School of Medicine – sequence: 19 givenname: John C. surname: Magee fullname: Magee, John C. organization: University of Michigan Medical School |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/23703680$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kUtv1DAURi1URKcDC_4AssQGFmn9SJyE3VANtNIAFQ-xtPy4oa4Se2o7lPn3GGa6qWDju_D5Pl2de4KOfPCA0HNKTikh7OwatqdMNJQ9QgvasLbivCFHaEFYS6qe8v4YnaR0Qwjpa9Y9QceMt4SLjizQ3fpXjqoUqOwMXvkwqdFBws7jSz8onxP-7vI1futGp-IOr3KE5NQb_BnSPJbfMGCFNyr-AHwVQ9qCye4n4I8hltRqguiM8vhDYZ0BnyHiL3m2u6fo8aDGBM8Oc4m-vVt_Pb-oNp_eX56vNpXhXceqQYDtFLfaNHRorFaaU9WxwQ4dYUPdCq0JtQq4EgSssKJmrTZMaWKZbhvCl-jVvncbw-0MKcvJJQPjqDyEOUla96TrO0FZQV8-QG_CHH3ZrlC16Lloy7NELw7UrCewchvdVMTIe6UFONsDpuhIEQZpXC52gy-i3SgpkX-OJotz-fdoJfH6QeK-9F_sof3OjbD7Pygv1lf7xG9CkKbQ |
CODEN | HPTLD9 |
CitedBy_id | crossref_primary_10_1097_CNQ_0000000000000121 crossref_primary_10_3389_fimmu_2020_00329 crossref_primary_10_1016_j_pepo_2017_03_024 crossref_primary_10_1016_j_transproceed_2016_01_029 crossref_primary_10_1016_j_jcmgh_2015_04_001 crossref_primary_10_3389_fphys_2020_538701 crossref_primary_10_1016_j_epag_2017_12_001 crossref_primary_10_1097_CLD_0000000000000150 crossref_primary_10_1016_j_dld_2021_09_011 crossref_primary_10_1016_j_jpedsurg_2017_08_048 crossref_primary_10_1016_j_clp_2022_07_006 crossref_primary_10_1016_j_epsc_2022_102339 crossref_primary_10_1016_j_jpeds_2022_03_038 crossref_primary_10_1097_MPG_0000000000002414 crossref_primary_10_1016_j_sempedsurg_2025_151475 crossref_primary_10_1097_MPG_0000000000000755 crossref_primary_10_1007_s40477_024_00938_0 crossref_primary_10_1002_hep_29905 crossref_primary_10_1097_PAS_0000000000000755 crossref_primary_10_1002_humu_22786 crossref_primary_10_1097_MOP_0000000000001380 crossref_primary_10_1016_j_jpedsurg_2017_11_018 crossref_primary_10_1097_MPG_0000000000002450 crossref_primary_10_3389_fphar_2023_1173542 crossref_primary_10_3389_fped_2022_918130 crossref_primary_10_1007_s00261_016_0865_x crossref_primary_10_31744_einstein_journal_2022RC0072 crossref_primary_10_1007_s40139_014_0040_4 crossref_primary_10_1097_HEP_0000000000000029 crossref_primary_10_1016_j_pathol_2021_09_023 crossref_primary_10_1542_peds_2015_3570 crossref_primary_10_1002_cld_428 crossref_primary_10_1007_s12519_018_0203_1 crossref_primary_10_1371_journal_pone_0138381 crossref_primary_10_1097_MD_0000000000016761 crossref_primary_10_1542_peds_2020_038596 crossref_primary_10_3348_jksr_2022_0090 crossref_primary_10_3389_fphys_2020_00966 crossref_primary_10_1016_j_jhep_2023_07_039 crossref_primary_10_1038_s41598_020_59379_4 crossref_primary_10_1016_j_jpedsurg_2015_08_040 crossref_primary_10_3390_diagnostics6010005 crossref_primary_10_1007_s00383_017_4172_6 crossref_primary_10_1038_nrgastro_2015_74 crossref_primary_10_2174_1573396318666220510130259 crossref_primary_10_1002_hep_32800 crossref_primary_10_1111_jgh_14575 crossref_primary_10_3928_19382359_20181018_01 crossref_primary_10_1136_archdischild_2020_319122 crossref_primary_10_1016_j_asjsur_2016_04_003 crossref_primary_10_1016_j_nrleng_2020_07_001 crossref_primary_10_1136_flgastro_2020_101554 crossref_primary_10_3389_fimmu_2023_1206025 crossref_primary_10_1002_wsbm_1303 crossref_primary_10_1097_PEC_0000000000001467 crossref_primary_10_1016_j_cld_2022_03_001 crossref_primary_10_1002_bdr2_1145 crossref_primary_10_1159_000371694 crossref_primary_10_1186_s12887_022_03491_z crossref_primary_10_1111_liv_14800 crossref_primary_10_1111_petr_14357 crossref_primary_10_1242_dmm_049326 crossref_primary_10_1053_j_semdp_2019_07_004 crossref_primary_10_1016_j_clinre_2019_06_006 crossref_primary_10_1177_03000605211012596 crossref_primary_10_1016_j_nrl_2019_02_001 crossref_primary_10_1016_j_jpeds_2014_05_038 crossref_primary_10_1371_journal_pgen_1007532 crossref_primary_10_1002_ajmg_a_63185 crossref_primary_10_1097_PAS_0000000000001146 crossref_primary_10_1002_hep_30515 crossref_primary_10_1007_s00247_021_05034_7 crossref_primary_10_1016_j_surg_2017_04_013 crossref_primary_10_1016_j_humpath_2014_01_002 crossref_primary_10_1097_MOG_0000000000000509 crossref_primary_10_1007_s00247_020_04840_9 crossref_primary_10_1111_hepr_13060 crossref_primary_10_1016_j_cmrp_2019_01_007 crossref_primary_10_4103_jwas_jwas_195_22 crossref_primary_10_1016_j_surg_2014_08_042 crossref_primary_10_1038_s41572_024_00533_x crossref_primary_10_1186_s12920_017_0259_0 crossref_primary_10_1038_s41598_019_41148_7 crossref_primary_10_1002_jgh3_12980 crossref_primary_10_1007_s00247_021_05148_y crossref_primary_10_1097_MPG_0000000000001334 crossref_primary_10_1136_bcr_2018_226222 crossref_primary_10_1016_j_surg_2018_12_003 crossref_primary_10_1155_2015_697238 crossref_primary_10_1016_j_jpeds_2018_04_001 crossref_primary_10_1097_MPG_0000000000000569 crossref_primary_10_1002_hep_32107 crossref_primary_10_1016_j_jhep_2016_04_032 crossref_primary_10_1097_AIA_0000000000000138 crossref_primary_10_3389_fphys_2021_658518 crossref_primary_10_1038_s41390_025_03804_9 |
Cites_doi | 10.1186/1471-2334-5-108 10.1111/j.1478-3231.2011.02578.x 10.1007/s00345-004-0405-0 10.1172/JCI200421153 10.1002/ajmg.1320450606 10.1093/brain/123.6.1102 10.1016/0167-5699(93)90244-F 10.1586/egh.09.61 10.1016/j.jaut.2006.01.001 10.1002/hep.24106 10.1055/s-0029-1233533 10.1007/s00383-004-1203-x 10.1016/S0140-6736(09)60946-6 10.1016/j.jpeds.2006.05.030 10.1055/s-2007-985068 10.1111/j.1442-200X.2009.03014.x 10.1016/j.jpedsurg.2003.09.044 10.1053/j.sempedsurg.2012.05.003 |
ContentType | Journal Article |
Copyright | 2013 by the American Association for the Study of Liver Diseases 2013 by the American Association for the Study of Liver Diseases. |
Copyright_xml | – notice: 2013 by the American Association for the Study of Liver Diseases – notice: 2013 by the American Association for the Study of Liver Diseases. |
CorporateAuthor | Childhood Liver Disease Research and Education Network |
CorporateAuthor_xml | – name: Childhood Liver Disease Research and Education Network |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7T5 7TM 7TO 7U9 H94 K9. 7X8 |
DOI | 10.1002/hep.26512 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Immunology Abstracts Nucleic Acids Abstracts Oncogenes and Growth Factors Abstracts Virology and AIDS Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts Virology and AIDS Abstracts Oncogenes and Growth Factors Abstracts Nucleic Acids Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic AIDS and Cancer Research Abstracts MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1527-3350 |
EndPage | 1731 |
ExternalDocumentID | 3112369421 23703680 10_1002_hep_26512 HEP26512 |
Genre | article Multicenter Study Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GeographicLocations | United States |
GeographicLocations_xml | – name: United States |
GrantInformation_xml | – fundername: National Center for Research Resources funderid: NIH (5M01 RR00069 (Denver); UL1RR025780 (Denver); UL1RR024153 (Pittsburgh); UL1RR024134 (Philadelphia); UL1RR024131 (San Francisco); UL1RR025005 (Baltimore); UL1RR025741 (Chicago) – fundername: The National Institute of Diabetes, Digestive and Kidney Diseases funderid: U54DK078377; DK 62530 (Baltimore); DK 62436 (Chicago); DK 62497 (Cincinnati); DK 62453 (Denver); DK 62445 (Mt Sinai); DK 62481 (Philadelphia); DK 62466 (Pittsburgh); DK 62500 (San Francisco); DK 62452 (St. Louis); DK 84536 (Indiana); DK 84575 (Seattle); DK 62470 (Houston); DK 84538 (Los Angeles); DK 84585 (Atlanta); DK 62456 (Michigan) – fundername: NIDDK NIH HHS grantid: U01 DK062453 – fundername: NIDDK NIH HHS grantid: DK 84536 – fundername: NCATS NIH HHS grantid: UL1 TR000150 – fundername: NIDDK NIH HHS grantid: U01 DK062445 – fundername: NCATS NIH HHS grantid: UL1 TR000006 – fundername: NCATS NIH HHS grantid: UL1TR000433 – fundername: NIDDK NIH HHS grantid: DK 62436 – fundername: NIDDK NIH HHS grantid: DK 62452 – fundername: NCATS NIH HHS grantid: UL1 TR000448 – fundername: NCATS NIH HHS grantid: UL1TR000130 |
GroupedDBID | --- --K .3N .55 .GA .GJ .Y3 05W 0R~ 10A 186 1B1 1CY 1L6 1OB 1OC 1ZS 1~5 24P 31~ 33P 3O- 3SF 3WU 4.4 4G. 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5RE 5VS 7-5 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAEDT AAESR AAEVG AAHHS AALRI AANHP AAONW AAQFI AAQQT AAQXK AASGY AAXRX AAXUO AAZKR ABCQN ABCUV ABEML ABIJN ABLJU ABMAC ABOCM ABPVW ABWVN ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACLDA ACMXC ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADEOM ADIZJ ADKYN ADMGS ADMUD ADNMO ADOZA ADXAS ADZMN ADZOD AECAP AEEZP AEIMD AENEX AEQDE AEUQT AFBPY AFFNX AFGKR AFPWT AFUWQ AFZJQ AHMBA AIACR AIURR AIWBW AJAOE AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BAWUL BDRZF BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DIK DPXWK DR2 DRFUL DRMAN DRSTM DU5 E3Z EBS EJD F00 F01 F04 F5P FD8 FDB FEDTE FGOYB FUBAC G-S G.N GNP GODZA H.X HBH HF~ HHY HHZ HVGLF HZ~ IHE IX1 J0M J5H JPC KBYEO KQQ LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M41 M65 MJL MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N4W N9A NF~ NNB NQ- O66 O9- OIG OK1 OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 QRW R.K R2- RGB RIG RIWAO RJQFR ROL RPZ RWI RX1 RYL SEW SSZ SUPJJ TEORI UB1 V2E V9Y W2D W8V W99 WBKPD WH7 WHWMO WIB WIH WIJ WIK WIN WJL WOHZO WQJ WRC WUP WVDHM WXI X7M XG1 XV2 ZGI ZXP ZZTAW ~IA ~WT AAYXX ABJNI ACZKN AFNMH AGQPQ AHQVU CITATION MEWTI WXSBR ACIJW CGR CUY CVF ECM EIF NPM 7T5 7TM 7TO 7U9 AAMMB AEFGJ AGXDD AIDQK AIDYY H94 K9. 7X8 |
ID | FETCH-LOGICAL-c3882-f6ed8a3dbc51f5dbab31a82fdf802f476bb01dae3a60ed6d6427bc2ab0d2b7503 |
IEDL.DBID | DR2 |
ISSN | 0270-9139 1527-3350 |
IngestDate | Thu Jul 10 22:20:59 EDT 2025 Fri Jul 25 22:55:07 EDT 2025 Thu Apr 03 07:03:39 EDT 2025 Thu Apr 24 23:07:57 EDT 2025 Tue Jul 01 03:33:36 EDT 2025 Wed Jan 22 17:07:41 EST 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Language | English |
License | 2013 by the American Association for the Study of Liver Diseases. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3882-f6ed8a3dbc51f5dbab31a82fdf802f476bb01dae3a60ed6d6427bc2ab0d2b7503 |
Notes | Potential conflict of interest: Dr. Haber owns stock in Merck. Dr. Molleston received grants from Schering‐Plough, Roche, Bristol‐Myers Squibb, and Vertex. Dr. Murray owns stock in Merck and received grants from Roche and Gilead. Dr. Romero received grants from Bristol‐Myers Squibb. Dr. Rosenthal consults for Merck, General Electric, and Ikaria and received grants from Bristol‐Myers Squibb, Vertex, and Gilead. Dr. Schwarz received grants from Roche. Dr. Sokol consults and owns stock in Yasoo Health and also consults for Roche and Ikaria. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | https://hdl.handle.net/2027.42/100275 |
PMID | 23703680 |
PQID | 1446936769 |
PQPubID | 996352 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_1490898612 proquest_journals_1446936769 pubmed_primary_23703680 crossref_citationtrail_10_1002_hep_26512 crossref_primary_10_1002_hep_26512 wiley_primary_10_1002_hep_26512_HEP26512 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | November 2013 2013-11-00 2013-Nov 20131101 |
PublicationDateYYYYMMDD | 2013-11-01 |
PublicationDate_xml | – month: 11 year: 2013 text: November 2013 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Hoboken |
PublicationTitle | Hepatology (Baltimore, Md.) |
PublicationTitleAlternate | Hepatology |
PublicationYear | 2013 |
Publisher | Wolters Kluwer Health, Inc |
Publisher_xml | – name: Wolters Kluwer Health, Inc |
References | 44 2004; 22 2002; 36 1990; 31 2004; 20 1993; 45 2010; 19 2011; 53 2009; 374 2011; 31 2009; 29 2010; 88 1993; 14 2004; 114 2004; 39 2010; 152A 2006; 26 2005; 5 2011; 41 1994; 15 2000; 123 2006; 149 2009; 3 2010; 52 2012; 21 2007; 27 2001; 116 2003; 67 Matthews (R10-22-20241201) 2011; 53 Anaya (R25-22-20241201) 2006; 26 Yang (R2-22-20241201) 2010; 52 Kim (R15-22-20241201) 2011; 41 Davenport (R1-22-20241201) 2006; 149 Rasmussen (R14-22-20241201) 2003; 67 Parker (R16-22-20241201) 2010; 88 Yoon (R13-22-20241201) 2001; 116 Feldman (R27-22-20241201) 2012; 21 Muraji (R6-22-20241201) 2009; 3 Bogdanos (R26-22-20241201) 2009; 29 Guttman (R22-22-20241201) 2011; 31 Rose (R23-22-20241201) 1993; 14 LeyvaVega (R8-22-20241201) 2010; 152A Herrmann (R18-22-20241201) 2004; 39 Broadley (RU24-22-20241201) 2000; 123 GarciaBarcelo (R9-22-20241201) 2010; 19 Amae (RU19-22-20241201) 2004; 20 Zerin (R20-22-20241201) 1994; 15 Carmi (R21-22-20241201) 1993; 45 Mack (R7-22-20241201) 2007; 27 De Tommaso (R3-22-20241201) 2005; 5 Shivakumar (R5-22-20241201) 2004; 114 Hartley (R12-22-20241201) 2009; 374 Riccabona (R17-22-20241201) 2004; 22 24761441 - Z Gastroenterol. 2014 Mar;52(3):251-2. |
References_xml | – volume: 52 start-page: 569 year: 2010 end-page: 572 article-title: Implication of early‐onset biliary atresia and extrahepatic congenital anomalies publication-title: Pediatr Int – volume: 31 start-page: 1485 year: 2011 end-page: 1493 article-title: Biliary atresia with associated structural malformations in Canadian infants publication-title: Liver Int – volume: 149 start-page: 393 year: 2006 end-page: 400 article-title: The biliary atresia splenic malformation syndrome: a 28 year single‐center retrospective study publication-title: J Pediatr – volume: 31 year: 1990 – volume: 45 start-page: 683 year: 1993 end-page: 693 article-title: Extrahepatic biliary atresia and associated anomalies: etiologic heterogeneity suggested by distinctive patterns of associations publication-title: Am J Med Genet – volume: 26 start-page: 208 year: 2006 end-page: 214 article-title: Familial clustering of autoimmune diseases in patients with type 1 diabetes mellitus publication-title: J Autoimmun – volume: 41 start-page: 227 year: 2011 end-page: 232 article-title: Heterotaxy syndrome publication-title: Korean Circ J – volume: 36 start-page: 904 issue: 4 Pt 1 year: 2002 end-page: 912 article-title: The significant human jagged 1 mutations detected in severe cases of biliary atresia publication-title: Hepatology – volume: 21 start-page: 192 year: 2012 end-page: 200 article-title: Biliary atresia: cellular dynamics and immune dysregulation publication-title: Semin Pediatr Surg – volume: 116 start-page: 32 year: 2001 end-page: 40 publication-title: Public Health Rep – volume: 20 start-page: 380 year: 2004 end-page: 383 article-title: Biliary atresia with associated complicated anorectal and urogenital malformations publication-title: Pediatr Surg Int – volume: 29 start-page: 241 year: 2009 end-page: 253 article-title: Autoantibodies and their antigens in autoimmune hepatitis publication-title: Semin Liver Dis – volume: 39 start-page: E20 year: 2004 end-page: E22 article-title: Extrahepatic biliary atresia and caudal regression syndrome in an infant of a diabetic mother publication-title: J Pediatr Surg – volume: 22 start-page: 73 year: 2004 end-page: 78 article-title: Assessment and management of newborn hydronephrosis publication-title: World J Urol – volume: 152A start-page: 886 year: 2010 end-page: 895 article-title: Genomic alterations in biliary atresia suggest region of potential disease susceptibility in 2q37.3 publication-title: Am J Med Genet Part A – volume: 53 start-page: 905 year: 2011 end-page: 914 article-title: DNA hypomethylation causes bile duct defects in zebrafish and is a distinguishing feature of infantile biliary atresia publication-title: Hepatology – volume: 88 start-page: 1008 year: 2010 end-page: 1016 article-title: Updated National Birth Prevalence estimates for selected birth defects in the United States, 2004–2006 publication-title: Birth Defects Res (Part A) Clin Mol Teratol – volume: 123 start-page: 1102 year: 2000 end-page: 1111 article-title: Autoimmune disease in first‐degree relatives of patients with multiple sclerosis: a UK survey publication-title: Brain – volume: 15 start-page: 306 year: 1994 end-page: 316 article-title: Hydronephrosis in the neonate and young infant publication-title: Curr Concept Semin Ultrasound CT MR – volume: 114 start-page: 322 year: 2004 end-page: 329 article-title: Obstruction of extrahepatic bile ducts by lymphocytes is regulated by IFN‐gamma in experimental biliary atresia publication-title: J Clin Invest – volume: 19 start-page: 2917 year: 2010 end-page: 2925 article-title: Genome‐wide association study identifies a susceptibility locus for biliary atresia on 10q24.2.* publication-title: Hum Mol Genet – volume: 14 start-page: 426 year: 1993 end-page: 430 article-title: Defining criteria for autoimmune diseases (Witebsky's postulates revisted) publication-title: Immun Today – volume: 374 start-page: 1704 year: 2009 end-page: 17013 article-title: Biliary atresia publication-title: Lancet – volume: 5 start-page: 108 year: 2005 article-title: High frequency of human cytomegalovirus DNA in the liver of infants with extrahepatic neonatal cholestasis publication-title: BMC Infect Dis – volume: 3 start-page: 599 year: 2009 end-page: 606 article-title: Biliary atresia: a new immunological insight into etiopathogenesis publication-title: Expert Rev Gastroenterol Hepatol – volume: 44 start-page: 1231 end-page: 1239 article-title: Cellular and humoral autoimmunity directed at bile duct epithelia in murine biliary atresia publication-title: Hepatology – volume: 27 start-page: 233 year: 2007 end-page: 242 article-title: The pathogenesis of biliary atresia: evidence for a virus‐induced autoimmune disease publication-title: Semin Liver Dis – volume: 67 start-page: 193 year: 2003 end-page: 201 article-title: National Birth Defects Prevention Study. Guidelines for case classification for the National Birth Defects Prevention Study publication-title: Birth Defects Res (Part A) Clin Mol Teratol – volume: 5 start-page: 108 year: 2005 ident: R3-22-20241201 article-title: High frequency of human cytomegalovirus DNA in the liver of infants with extrahepatic neonatal cholestasis. publication-title: BMC Infect Dis doi: 10.1186/1471-2334-5-108 – volume: 116 start-page: 3240 issue: Suppl 1 year: 2001 ident: R13-22-20241201 article-title: The National Birth Defects Prevention Study. publication-title: Public Health Rep – volume: 31 start-page: 14851493 year: 2011 ident: R22-22-20241201 article-title: ; the Canadian Pediatric Hepatology Research Group. Biliary atresia with associated structural malformations in Canadian infants. publication-title: Liver Int doi: 10.1111/j.1478-3231.2011.02578.x – volume: 88 start-page: 10081016 year: 2010 ident: R16-22-20241201 article-title: ; National Birth Defects Prevention Network. Updated National Birth Prevalence estimates for selected birth defects in the United States, 2004-2006. publication-title: Birth Defects Res (Part A) Clin Mol Teratol – volume: 22 start-page: 7378 year: 2004 ident: R17-22-20241201 article-title: Assessment and management of newborn hydronephrosis. publication-title: World J Urol doi: 10.1007/s00345-004-0405-0 – volume: 114 start-page: 322329 year: 2004 ident: R5-22-20241201 article-title: Obstruction of extrahepatic bile ducts by lymphocytes is regulated by IFNgamma in experimental biliary atresia. publication-title: J Clin Invest doi: 10.1172/JCI200421153 – volume: 45 start-page: 683693 year: 1993 ident: R21-22-20241201 article-title: Extrahepatic biliary atresia and associated anomalies: etiologic heterogeneity suggested by distinctive patterns of associations. publication-title: Am J Med Genet doi: 10.1002/ajmg.1320450606 – volume: 123 start-page: 11021111 year: 2000 ident: RU24-22-20241201 article-title: Autoimmune disease in firstdegree relatives of patients with multiple sclerosis: a UK survey. publication-title: Brain doi: 10.1093/brain/123.6.1102 – volume: 14 start-page: 426430 year: 1993 ident: R23-22-20241201 article-title: Defining criteria for autoimmune diseases (Witebskys postulates revisted). publication-title: Immun Today doi: 10.1016/0167-5699(93)90244-F – volume: 3 start-page: 599606 year: 2009 ident: R6-22-20241201 article-title: Biliary atresia: a new immunological insight into etiopathogenesis. publication-title: Expert Rev Gastroenterol Hepatol doi: 10.1586/egh.09.61 – volume: 26 start-page: 208214 year: 2006 ident: R25-22-20241201 article-title: Familial clustering of autoimmune diseases in patients with type 1 diabetes mellitus. publication-title: J Autoimmun doi: 10.1016/j.jaut.2006.01.001 – volume: 53 start-page: 905914 year: 2011 ident: R10-22-20241201 article-title: DNA hypomethylation causes bile duct defects in zebrafish and is a distinguishing feature of infantile biliary atresia. publication-title: Hepatology doi: 10.1002/hep.24106 – volume: 67 start-page: 193201 year: 2003 ident: R14-22-20241201 article-title: ; National Birth Defects Prevention Study. Guidelines for case classification for the National Birth Defects Prevention Study. publication-title: Birth Defects Res (Part A) Clin Mol Teratol – volume: 29 start-page: 241253 year: 2009 ident: R26-22-20241201 article-title: Autoantibodies and their antigens in autoimmune hepatitis. publication-title: Semin Liver Dis doi: 10.1055/s-0029-1233533 – volume: 20 start-page: 380383 year: 2004 ident: RU19-22-20241201 article-title: Biliary atresia with associated complicated anorectal and urogenital malformations. publication-title: Pediatr Surg Int doi: 10.1007/s00383-004-1203-x – volume: 41 start-page: 227232 year: 2011 ident: R15-22-20241201 article-title: Heterotaxy syndrome. publication-title: Korean Circ J – volume: 374 start-page: 170417013 year: 2009 ident: R12-22-20241201 article-title: Biliary atresia. publication-title: Lancet doi: 10.1016/S0140-6736(09)60946-6 – volume: 149 start-page: 393400 year: 2006 ident: R1-22-20241201 article-title: Underhill, MieliVergani G, Portmann B, Hadzic N. The biliary atresia splenic malformation syndrome: a 28 year singlecenter retrospective study. publication-title: J Pediatr doi: 10.1016/j.jpeds.2006.05.030 – volume: 27 start-page: 233242 year: 2007 ident: R7-22-20241201 article-title: The pathogenesis of biliary atresia: evidence for a virusinduced autoimmune disease. publication-title: Semin Liver Dis doi: 10.1055/s-2007-985068 – volume: 19 start-page: 29172925 year: 2010 ident: R9-22-20241201 article-title: Genomewide association study identifies a susceptibility locus for biliary atresia on 10q24.2.. publication-title: Hum Mol Genet – volume: 15 start-page: 306316 year: 1994 ident: R20-22-20241201 article-title: Hydronephrosis in the neonate and young infant. publication-title: Curr Concept Semin Ultrasound CT MR – volume: 52 start-page: 569572 year: 2010 ident: R2-22-20241201 article-title: Implication of earlyonset biliary atresia and extrahepatic congenital anomalies. publication-title: Pediatr Int doi: 10.1111/j.1442-200X.2009.03014.x – volume: 39 start-page: E20E22 year: 2004 ident: R18-22-20241201 article-title: Extrahepatic biliary atresia and caudal regression syndrome in an infant of a diabetic mother. publication-title: J Pediatr Surg doi: 10.1016/j.jpedsurg.2003.09.044 – volume: 152A start-page: 886895 year: 2010 ident: R8-22-20241201 article-title: Genomic alterations in biliary atresia suggest region of potential disease susceptibility in 2q37.3. publication-title: Am J Med Genet Part A – volume: 21 start-page: 192200 year: 2012 ident: R27-22-20241201 article-title: Biliary atresia: cellular dynamics and immune dysregulation. publication-title: Semin Pediatr Surg doi: 10.1053/j.sempedsurg.2012.05.003 – reference: 24761441 - Z Gastroenterol. 2014 Mar;52(3):251-2. |
SSID | ssj0009428 |
Score | 2.4716506 |
Snippet | The etiology of biliary atresia (BA) is unknown. Given that patterns of anomalies might provide etiopathogenetic clues, we used data from the North American... |
SourceID | proquest pubmed crossref wiley |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1724 |
SubjectTerms | Abnormalities, Multiple - epidemiology Adult Biliary Atresia - etiology Defects Female Hepatology Humans Male Prospective Studies United States - epidemiology |
Title | Extrahepatic Anomalies in Infants With Biliary Atresia: Results of a Large Prospective North American Multicenter Study |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fhep.26512 https://www.ncbi.nlm.nih.gov/pubmed/23703680 https://www.proquest.com/docview/1446936769 https://www.proquest.com/docview/1490898612 |
Volume | 58 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwELYQh4pLS0tLly6VQT30ksVxYm9CTwtatKBSIVRUDpUiP0XUbYJ2syrw6-txHiteUtVbJDu245mxZzIz3yD0iTGmWBKawDpucAaKVIHQoQiYNqF1HGIkgwTn0298chGfXLLLFfSlzYWp8SG6H24gGf68BgEXcr63BA29MtcDypmvMAyxWqAQnS-ho9LY11V1VhcB73LaogoRute9ef8ueqRg3tdX_YVz9Ar9bJdax5n8GiwqOVB3D1Ac__Nb1tHLRhHFo5pzXqMVU7xBL04bV_sG-jO-qdxBZCDiWuFRUf52GruZ47zAx4WF6Bn8I6-u8EE-zd3EeARJJ7nYx-dmvpi61tJigb9CoDk-m5VtRif2jiLcOoqwTwCGCFEzwxDTePsWXRyNvx9OgqZKQ6AiUM8tNzoRkZaKOepqKWQUioRabRNCbTzkUpJQCxMJTozm2hk8Q6mokERTCV7Ud2i1KAvzHmFulEh1aL3SQBKVpPGQKRmrIRFuIN5Dn1t6ZaqBMIdKGtOsBl-mmduVzG9kD-12Xa9r3I6nOvVbomeN6M4zMJBTwLFLe2ina3ZCB54UUZhyAX3AXZpwGGKzZpZuFhoBpllC3GI9yZ-fPpuMz_zD1r93_YDWKBTk8NmQfbRazRZm26lFlfzo-f8vkSUJZg |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqIgGXQnm025ZiEAcu2TpO7E0QlwW22sJuVVWt6KWK_FSjbpNqN6sCvx6P86jKQ0LcItmxE8-MPeOZ-QahN4wxxZLQBNZxgzNQpAqEDkXAtAmt4xAjGSQ4Tw_5-DT-fMbOVtD7NhemxofoLtxAMvx-DQIOF9J7t6ihF-a6TzmDEsP3oKI3IOd_Or4Fj0pjX1nV2V0E_MtpiytE6F736t3T6DcV867G6o-c_UfovP3YOtLksr-sZF_9-AXH8X__5jFaa3RRPKyZZx2tmOIJuj9tvO1P0c3oW-X2IgNB1woPi_LKKe1mgfMCHxQWAmjw17y6wB_yWe5mxkPIO8nFO3xsFsuZay0tFngCseb4aF62SZ3Y-4pw6yvCPgcYgkTNHENY4_dn6HR_dPJxHDSFGgIVgYZuudGJiLRUzBFYSyGjUCTUapsQauMBl5KEWphIcGI0187mGUhFhSSaSnCkPkerRVmYTYS5USLVofV6A0lUksYDpmSsBkS4gXgPvW0JlqkGxRyKacyyGn-ZZm5VMr-QPfS663pdQ3f8qdNOS_Wskd5FBjZyClB2aQ-96pqd3IEzRRSmXEIf8JgmHIbYqLmlm4VGAGuWEPexnuZ_nz4bj478w9a_d32JHoxPppNscnD4ZRs9pFCfwydH7qDVar40L5yWVMldLww_ARmQDYI |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELemIU28MNiAFQZ4iAde0jlO7CbsqbBWHWxTNTGxB6TIn1q0klRtKj7--vmcj2kDJMRbJDu247uz73J3v0PoDWNMsSQ0gXXc4AwUqQKhQxEwbULrOMRIBgnOJ6d8ch5_vGAXa-igzYWp8SG6H24gGf68BgGfa7t_Axp6aeZ9yhlUGL4Xc5JC3YbDsxvsqDT2hVWd2UXAvZy2sEKE7nev3r6MftMwbyus_sYZb6Kv7VrrQJOr_qqSffXrDozjf37MQ_Sg0UTxsGadR2jNFFto46TxtW-j76MflTuJDIRcKzwsym9OZTdLnBf4qLAQPoO_5NUlfp_PcjcxHkLWSS7e4TOzXM1ca2mxwMcQaY6ni7JN6cTeU4RbTxH2GcAQImoWGIIafz5G5-PR5w-ToCnTEKgI9HPLjU5EpKVijrxaChmFIqFW24RQGw-4lCTUwkSCE6O5dhbPQCoqJNFUghv1CVovysLsIMyNEqkOrdcaSKKSNB4wJWM1IMINxHvobUuvTDUY5lBKY5bV6Ms0c7uS-Y3soddd13kN3PGnTrst0bNGdpcZWMgpANmlPbTXNTupA1eKKEy5gj7gL004DPG0ZpZuFhoBqFlC3GI9yf8-fTYZTf3Ds3_v-gptTA_H2fHR6afn6D6F4hw-M3IXrVeLlXnhVKRKvvSicA3sywwx |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Extrahepatic+Anomalies+in+Infants+With+Biliary+Atresia%3A+Results+of+a+Large+Prospective+North+American+Multicenter+Study&rft.jtitle=Hepatology+%28Baltimore%2C+Md.%29&rft.au=Schwarz%2C+Kathleen+B.&rft.au=Haber%2C+Barbara+H.&rft.au=Rosenthal%2C+Philip&rft.au=Mack%2C+Cara+L.&rft.date=2013-11-01&rft.issn=0270-9139&rft.volume=58&rft.issue=5&rft.spage=1724&rft.epage=1731&rft_id=info:doi/10.1002%2Fhep.26512&rft.externalDBID=n%2Fa&rft.externalDocID=10_1002_hep_26512 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0270-9139&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0270-9139&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0270-9139&client=summon |